Osteopore Ltd - Asset Resilience Ratio

Latest as of December 2025: 22.60%

Osteopore Ltd (OSX) has an Asset Resilience Ratio of 22.60% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check Osteopore Ltd (OSX) strategic investment index to assess the company's strategic physical and investment asset allocation.

Liquid Assets

AU$626.97K
≈ $443.62K USD Cash + Short-term Investments

Total Assets

AU$2.77 Million
≈ $1.96 Million USD All company assets

Resilience Assessment

Good
Financial Resilience Level

Asset Resilience Ratio Trend (2018–2025)

This chart shows how Osteopore Ltd's Asset Resilience Ratio has changed over time. See OSX net asset quality score to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Osteopore Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see OSX market cap overview.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents AU$626.97K 22.6%
Short-term Investments AU$0.00 0%
Total Liquid Assets AU$626.97K 22.60%

Asset Resilience Insights

  • Good Liquidity Position: Osteopore Ltd maintains a healthy 22.60% of assets in liquid form.
  • This level provides good financial flexibility while maintaining productive asset deployment.
  • The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Osteopore Ltd Industry Peers by Asset Resilience Ratio

Compare Osteopore Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Pegavision
TW:6491
Medical Instruments & Supplies 17.14%
Ansell Ltd
AU:ANN
Medical Instruments & Supplies 7.53%
Nanosonics Ltd
AU:NAN
Medical Instruments & Supplies 46.84%
SDI Ltd
AU:SDI
Medical Instruments & Supplies 3.36%
Austco Healthcare Ltd
AU:AHC
Medical Instruments & Supplies 15.90%
Nyxoah
BR:NYXH
Medical Instruments & Supplies 12.40%
Ocumetics Technology Corp
V:OTC
Medical Instruments & Supplies 0.00%
ZEN Graphene Solutions Ltd
V:ZEN
Medical Instruments & Supplies 4.79%

Annual Asset Resilience Ratio for Osteopore Ltd (2018–2025)

The table below shows the annual Asset Resilience Ratio data for Osteopore Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-12-31 0.21% AU$5.92K
≈ $4.19K
AU$2.77 Million
≈ $1.96 Million
+0.03pp
2024-12-31 0.18% AU$5.75K
≈ $4.07K
AU$3.13 Million
≈ $2.22 Million
+0.02pp
2023-12-31 0.17% AU$5.56K
≈ $3.93K
AU$3.34 Million
≈ $2.37 Million
-0.35pp
2022-12-31 0.51% AU$18.52K
≈ $13.11K
AU$3.62 Million
≈ $2.56 Million
-2.85pp
2021-12-31 3.36% AU$201.62K
≈ $142.66K
AU$6.01 Million
≈ $4.25 Million
+3.20pp
2020-12-31 0.16% AU$16.40K
≈ $11.60K
AU$10.25 Million
≈ $7.25 Million
-0.21pp
2019-12-31 0.37% AU$15.79K
≈ $11.17K
AU$4.28 Million
≈ $3.03 Million
+0.18pp
2018-12-31 0.18% AU$9.94K
≈ $7.03K
AU$5.40 Million
≈ $3.82 Million
--
pp = percentage points

About Osteopore Ltd

AU:OSX Australia Medical Instruments & Supplies
Market Cap
$1.74 Million
AU$2.46 Million AUD
Market Cap Rank
#30102 Global
#1772 in Australia
Share Price
AU$0.00
Change (1 day)
+0.00%
52-Week Range
AU$0.00 - AU$0.03
All Time High
AU$15.65
About

Osteopore Limited, a regenerative medicine company, engages in the production of 3D-printed biomimetic and bioresorbable implants in Vietnam, South Korea, the Philippines, Singapore, India, Taiwan, Indonesia, the Netherlands, United Arab Emirates, Australia, and internationally. The company commercializes products designed to enable natural bone healing across multiple therapeutic areas. Its tech… Read more